Many in the AI community believe that the next major revolution will be the era of self-improving AI where AI can improve ...

Fast, fairly priced hosting from a company that isn't trying to rip you off.

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

Anthropic’s Cowork brings Claude Code–style AI agents to the desktop, letting Claude access and manage local files and browse ...

Unless you worked for Ford’s plastics, paint and vinyls division in the 1980s, you probably don’t know the name Jim Moylan. But you might well know the idea that made this unknown engineer who ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Simple keys in Hollow Knight: Silksong are used to open doors scattered around Pharloom, but they're few and far between. As you're exploring Silksong, you've probably come across a few locked doors.